日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

BCMA-CD19 armored compound CAR T cells in systemic lupus erythematosus: extended follow-up of a phase 1 clinical trial

BCMA-CD19 修饰的 CAR-T 细胞治疗系统性红斑狼疮:一项 1 期临床试验的长期随访

Hong, Ming; Wang, Mingxia; Zeng, Ronghao; Ding, Ling; He, Shanzhi; Lan, Ting; DeStefano, Vincent M; Wada, Masayuki; Pinz, Kevin; Chow, Jennifer E; Choi, Byeong Hyeok; Hagag, Nabil; Wang, Min; Ma, Yu; Luo, Jing; Liang, Yingwen; Ding, Shihao; Lu, Ziji; Zhang, Wenli; Ma, Yupo; Wang, Weijia

Bridging data gaps of rare conditions in ICU: a multi-disease adaptation approach for clinical prediction

弥合ICU罕见病数据缺口:一种用于临床预测的多疾病适应性方法

Zhu, Mingcheng; Liu, Yu; Luo, Zhiyao; Zhu, Tingting

In situ tracking of glycoRNAs on single-cell surface to reveal RNA heterogeneity and transport mechanism

利用原位追踪技术在单细胞表面追踪糖基化RNA,揭示RNA异质性和转运机制

Gong, Meilin; Tang, Xiaoqi; Xie, Zuowei; Niu, Ben; Deng, Ruijia; Fu, Wenjuan; Yang, Yingjie; Tang, Yu; Luo, Jie; Sheng, Jing; Zhang, Ying; Chen, Ming; Chang, Kai

SAMHD1 drives immunosuppression in non-small cell lung cancer by promoting macrophage infiltration and restricting oncolytic adenovirus replication.

SAMHD1 通过促进巨噬细胞浸润和限制溶瘤腺病毒复制来驱动非小细胞肺癌的免疫抑制。

Hu Shichuan, Xu Jian, Wang Zhiwu, Zhang Yong, Zhao Chang, Liu Yu, Luo Feng, Cheng Ping, Wang Jiantao, Zhao Jing

Efficacy and safety of neoadjuvant treatment of trastuzumab and pyrotinib plus dalpiciclib in HR-negative/HER2-positive breast cancer: an exploratory, open-label phase II study

曲妥珠单抗和吡咯替尼联合达匹西利新辅助治疗HR阴性/HER2阳性乳腺癌的疗效和安全性:一项探索性、开放标签的II期研究

Xiao, Zhi; Chen, Feiyu; Liao, Liqiu; Luo, Shayang; Liu, Xuan; Liu, Xiangyan; Xu, Tao; Hu, Yu; Luo, Na; Wang, Wenlong; Cao, Jing; Wang, Kuansong; Zhou, Haiyan; Ding, Nianhua; Li, Yan; Huang, Juan; Wang, Shouman

SIRT1 deficiency promotes age-related heart failure through enhancing ferroptosis via GATA4-HADHA-GPX4 axis.

SIRT1 缺陷通过 GATA4-HADHA-GPX4 轴增强铁死亡,从而促进与年龄相关的心力衰竭。

Duan Yu, Luo Yingchun, Han Xuejie, Yu Hui, Liu Hanwen, Zhou Yun, Gao Yunlong, Xu Qian, Wei Ying, Min Ruoxin, Hong Yong, Ji Xuanrui, Jia Haibo, Li Yue, Zhang Yun

The identification of potent nonopioid analgesics and their potential for perioperative use

鉴定强效非阿片类镇痛药及其在围手术期应用的潜力

Deng, Chaoyi; Deng, Yu; Luo, Xudong; Lu, Junyu; Li, Chenyang; Gao, Peiwen; Xie, Xiaoyu; Xiang, Bingbing; Liu, Sicheng; Liu, Xingxing; Li, Xiaoxiao; Chang, Pan; Wu, Xia; Zhao, Guoyan; Gong, Deying; Wang, Jing; Zhou, Cheng; Liu, Jin; Zhu, Tao; Luo, Fengming; Zhang, Wensheng

De-2-hydroxyisobutyrylation of clusterin modulates neuropathology and memory deficits in an Alzheimer's disease mouse model.

簇蛋白的去-2-羟基异丁酰化作用调节阿尔茨海默病小鼠模型中的神经病理学和记忆缺陷。

Peng Xiaoping, Ouyang Chaoyue, Ma Fubin, Liu Yu, Luo Lv, Xing Jiawei, Feng Sifan, Li Li, Zhang Jiahao, Wang Jiaying, Cheng Helei, Zhang Tianying, Chen Feng, Wang Yan, Cui Lili

Discovery of a potent and orally bioavailable type Ⅰ PRMTs inhibitor for triple-negative breast cancer treatment

发现一种强效且口服生物利用度高的Ⅰ型PRMTs抑制剂,用于治疗三阴性乳腺癌

Zhou, Shu-Yan; Zhang, Qiang-Sheng; Li, Lu; Liu, Zhi-Hao; Hu, Xiang; Chen, Xue-Ying; Li, Xiao; Feng, Zhan-Zhan; Wan, Guo-Quan; Yu, Luo-Ting

Expert consensus on the detection and clinical application of tumor mutational burden

关于肿瘤突变负荷的检测和临床应用的专家共识

Guo, Zhenying; Xu, Chunwei; Zhang, Shirong; Hao, Yue; Hu, Xiaotong; Zhao, Ming; Xiang, Chan; Piao, Yingshi; Sun, Pingli; Xiang, Xueping; Zhao, Jing; Wu, Huanwen; Li, Weixing; Yu, Jinpu; Yuan, Jingping; Wang, Shuangshuang; Wang, Cong; Gu, Yun; Lv, Bingjian; Zhang, Liping; Liu, Yueping; Cui, Xiaobin; Gu, Weizhong; Li, Yining; Wang, Wei; Yang, Wenjun; Long, Weiguo; Xiang, Jingjing; Mou, Hong; Liu, Biao; Ruan, Huajuan; Wang, Yubin; Zhu, Yongjie; Wang, Feng; Wang, Zhonghua; Feng, Xiaomin; Liu, Xing; Li, Peng; Deng, Min; Lian, Bin; Mao, Lili; Wang, Qian; Wang, Wenxian; Song, Zhengbo; Li, Ziming; Zhong, Wenzhao; Wang, Zhijie; Ren, Shengxiang; Fang, Wenfeng; Zhang, Yongchang; Liu, Jingjing; Cai, Xiuyu; Liu, Anwen; Li, Wen; Zhan, Ping; Liu, Hongbing; Lv, Tangfeng; Miao, Liyun; Min, Lingfeng; Chen, Yu; Zhang, Yu; Wang, Feng; Jiang, Zhansheng; Lin, Gen; Huang, Long; Pu, Xingxiang; Lin, Rongbo; Liu, Weifeng; Rao, Chuangzhou; Lv, Dongqing; Yu, Zongyang; Shen, Peng; Li, Xiaoyan; Tang, Chuanhao; Zhou, Chengzhi; Zhang, Junping; Xue, Junli; Guo, Hui; Chu, Qian; Meng, Rui; Wu, Jingxun; Zhang, Rui; Zhou, Jin; Zhu, Zhengfei; Li, Yongheng; Qiu, Hong; Xia, Fan; Lu, Yuanyuan; Chen, Xiaofeng; Ge, Rui; Dai, Enyong; Han, Yu; Zhang, Jian; Ji, Yinghua; Liang, Xianbin; Zhang, Hongmei; Ma, Xuelei; Liu, Xuewen; Yao, Yu; Luo, Peng; Pan, Weiwei; Pang, Fei; Wu, Fan; Gu, Dejian; Wang, Li; Wang, Liping; Zhu, Youcai; Lin, Li; Li, Weiwen; Lin, Xinqing; Cai, Jing; Xu, Ling; Li, Jisheng; Jiao, Xiaodong; Li, Kainan; Wei, Jia; Feng, Huijing; Wang, Lin; Du, Yingying; Yao, Wang; Shi, Xuefei; Niu, Xiaomin; Yuan, Dongmei; Yao, Yanwen; Zhang, Yinbin; Song, Binbin; Li, Wenfeng; Fu, Jianfei; Wang, Hong; Ye, Mingxiang; Wang, Dong; Wang, Zhaofeng; Ji, Qing; Fang, Yuan; Wei, Qing; Wang, Zhen; Wan, Bin; Lv, Donglai; Li, Xiaofeng; Yang, Shengjie; Kang, Jing; Zhang, Jiatao; Zhang, Chao; Shi, Lin; Wang, Yina; Li, Bihui; Zhang, Zhang; Wang, Ke; Liu, Zhefeng; Yang, Nong; Wu, Lin; Chen, Xiaobing; Jin, Gu; Li, Zhongwu; Li, Miao; Wang, Guansong; Wang, Jiandong; Fang, Meiyu; Fang, Yong; Wang, Xiaojia; Chen, Jing; Zhang, Yiping; Zhu, Xixu; Shen, Yi; Ma, Shenglin; Wang, Biyun; Si, Lu; Song, Yong; Lu, Yuanzhi; Liu, Aijun; Han, Yuchen